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Intercontinental Dissemination of IMP-13-Producing Pseudomonas aeruginosa
Belonging in Sequence Type 621
IMP-type metallo--lactamases (MBLs) were the first ac-
quired MBLs detected in Gram-negative pathogens, in the
early 1990s, and are among the most relevant due to their
worldwide distribution (12, 18). Several IMP-type variants
have been described (3). IMP-13 was first detected in clinical
isolates of Pseudomonas aeruginosa from Italy (16), where
IMP-13 has become a widespread carbapenem resistance de-
terminant, even involved in relatively large outbreaks (11, 13,
17). IMP-13 was also occasionally detected in P. aeruginosa
isolates from other European countries, including Austria
(7), Romania (9), and France (6). Interestingly, the IMP-
13-producing Italian isolates were found to belong in the
same clonal lineage (13), and a clonal relationship with this
lineage was also demonstrated for a Romanian isolate (9).
In these isolates, the blaIMP-13 gene was found to be carried
in different class 1 integron structures (InPSG, In88, and
In89), usually located on the chromosome or, more rarely,
on plasmids (11, 13, 16).
IMP-13-producing P. aeruginosa isolates have also been de-
tected in Argentina, where IMP-13 and IMP-16 represent the
only IMP-type MBLs thus far reported (1, 4, 15). In this work,
we investigated 20 IMP-13-producing P. aeruginosa isolates (19
clinical isolates and 1 environmental isolate) from an outbreak in
Argentina (15) and compared them with P. aeruginosa AV65, as
a representative of the IMP-13-producing clone spreading in Italy
(13). The IMP-13-producing isolate from Romania (Pa247), pre-
viously described as clonally related to the Italian clone (9), was
also included in the comparative analysis.
Pulsed-field gel electrophoresis (PFGE) and multilocus se-
quence typing (MLST) were performed according to published
protocols (5, 10). Sequence type (ST) numbers were assigned
using the pubMLST database (http://pubmlst.org/paeruginosa/).
Characterization of the variable region of class 1 integrons and
their 5 flanking sequences were performed by a PCR mapping
and sequencing approach as previously reported (11, 16). The
chromosomal or plasmid location of the -lactamase gene was
investigated by the I-CeuI and S1 nuclease-mapping tech-
niques as described previously (2, 8). Under the assayed con-
ditions, S1 digestion converts plasmids to linear DNA forms
without cutting the genomic DNA (2), while I-CeuI only cuts
into the genomic DNA (8).
Following digestion with SpeI, all the Argentinean iso-
lates exhibited PFGE profiles that were identical or different
by no more than three bands (Fig. 1), revealing clonal re-
latedness. A total of 8 clonal variants (A1 to A8) were
identified (Fig. 1). The PFGE profiles of the Argentinean
isolates appeared to be also related with that of AV65, with
a difference of 2 to 6 bands (Fig. 1), suggesting a possible
clonal relatedness between the Argentinean isolates and the
Italian epidemic clone.
By MLST analysis, the AV65 and Pa247 isolates and all
the Argentinean isolates were identified as belonging in
ST621. Interestingly, the same ST was also reported for the
IMP-13-producing isolate from Austria (7). Altogether,
these results revealed a common genetic lineage for the
IMP-13-producing P. aeruginosa isolates circulating world-
wide.
Characterization of the variable regions of the class 1 inte-
grons carrying the blaIMP-13 cassette from the P. aeruginosa
isolates from Argentina revealed structures identical to those
previously found in European isolates. In particular, most Ar-
gentinean isolates harbored integron InPSG (11, 13), which
was also the most common integron platform among Italian
isolates (13) and that found in isolates from Romania (9) and
Austria (7). Moreover, sequence analysis showed that InPSG
from the Argentinean isolates was inserted into a Tn5051-like
transposon at the same res insertion site already described for
the InPSG-harboring Italian isolates (11), suggesting a com-
mon origin for these genetic structures. In the remaining Ar-
gentinean isolate, the blaIMP-13 cassette was carried as a single
gene cassette by In88, which was also described to occur in one
of the IMP-13-producing Italian isolates (13) and could be
derived from InPSG by excision of the aacA4 cassette present
in the second position.
Efforts aimed at purifying plasmids carrying blaIMP-13 (14)
or transferring the resistance determinant by conjugation
(11) or transformation (14) were unsuccessful. Southern
blot hybridization, using a blaIMP-13 probe and a 16S rRNA
probe after I-CeuI digestion and PFGE separation, showed
that the blaIMP gene was chromosomally located, since the
bands that hybridized with the blaIMP probe also hybridized
with the 16S rRNA probe. Southern blot analysis of PFGE
of SpeI-restricted genomic DNAs with the blaIMP probe
detected the resistance marker in the same fragment in all
isolates, while for a single isolate the resistance marker was
also detected in an additional fragment, suggesting the pos-
sibility of in vivo rearrangement events when the resistance
determinant is carried on transposable genetic structures
(data not shown).
The overall genomic relatedness of the IMP-13-producing
isolates and the fact that the blaIMP-13 gene was inserted in a
conserved genetic context point to a common ancestry for the
FIG. 1. PFGE patterns of IMP-13-producing P. aeruginosa isolates.
Lane 9, Italian isolate AV65; lane 15, IMP-13-producing environmen-
tal isolate from Argentina; Lanes 1 to 8, 10 to 14, and 16 to 21,
IMP-13-producing clinical isolates from Argentina. DNA size stan-
dards are indicated on the left.
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IMP-13-producing strains disseminated in South America and
Europe and underscore the role of the ST621 clonal lineage as
a highly successful P. aeruginosa epidemic clone.
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